Severe fatigue and a significantly reduced health-related quality of life (HRQoL) have been described in patients with chronic fatigue syndrome (CFS) in comparison with patients affected by chronic hepatitis C (CHC) and other chronic medical conditions. We examined 39 CFS and 49 CHC patients to explore whether fatigue and a poor HRQoL represent a greater medical and social problem in CFS than in CHe. The severity of fatigue and the HRQoL were assessed using the Fatigue Impact Scale (FIS) and the Health Status Questionnaire Short Form-36 (SF-36), respectively. The statistical analysis showed both a higher score offatigue and a lower HRQoL in CFS than in CHC patients. Furthermore, in CUC patients the FIS evaluation showed a significantly reduced score of the psychosocial domain in comparison with the other domains. Multivariate linear regression analysis revealed female gender as the most important positive variable in chronic hepatitis C patients for total score of FIS. In conclusion, CFS was associated with a severe and disabling fatigue and an impaired HRQOL. In particular, both fatigue and all aspects of HRQOL perceived by CFS patients were significantly impaired compared to CHC patients. Consequently, management of fatigue should be considered a priority in order to improve HRQOL in CFS patients. In CHC patients the impact of fatigue on HRQoL was less significant than in CFS patients, even though the FIS evaluation showed a significant impairment of the psychosocial domain.
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In practical medicine "fatigue" represents one of the most important and disabling symptoms reported by many patients, and it is amongst the most common symptoms for which individuals seek medical attention (1-2). In the mid-1980s a new diagnostic entity, called "chronic fatigue syndrome" (CFS), was recognized by the U.S. Centers for Disease Control and Prevention (CDC) with a well-defined working case definition, revised in 1994 (3) (4) (5) (6) . To date there is no proven pathomechanism to satisfactorily explain this disorder, even though many hypotheses have been advanced: infectious, toxic, immunological, psychological and neuroendocrine factors seem to play a crucial role in inducing a cascade of events that lead to the production of oxidative damage (7) . Many of the symptoms of CFS may be due to high circulating levels of some Th2 cytokines produced by a hyperactive immune response to a triggering factor (e.g.: a viral infection), and for this reason, the syndrome is also called "Chronic Fatigue Immune Dysfunction Syndrome" (CFIDS) (8) . CFS is characterised by severe prolonged fatigue, and decreases in cognition and other physiological functions, resulting in severe loss of health-related quality of life (HRQoL) more than that observed in other chronic medical conditions (9) (10) . On the other hand, the self-perceived HRQoL of these patients could influence the clinical presentation of the syndrome in a negative way ( II ).
Over time, "fatigue" and HRQoL have been more and more important as indicators of the clinical and psychological status of patients affected by chronic conditions (12) (13) (14) . In particular, a relevant prevalence of "fatigue" and a significant impairment of HRQoL have been described in patients with chronic hepatitis C (CHC) in comparison with patients living with other chronic conditions [e.g.: oncological patients, patients with chronic hepatitis B virus (HBV) infection, etc.] (15) (16) . To date, the causal factors of a reduced HRQoL in such patients are poorly understood, even though psychological and social impact of Hepatitis C Virus (HCV) infection diagnosis, as well as HCV itself and interferon treatment, seem to play a crucial role (17) (18) (19) . On the other hand, neither the stage of the liver disease nor the viral load nor the presence of extrahepatic manifestations seem to influence the HRQoL (20) .
On the basis of these considerations, the aims of the present study are to realize a comparative analysis of HRQoL between CFS patients and a sample ofCHC patients, and to investigate the extent to which sociodemographic (age, gender, partner and employment status), illness-related (illness duration) and fatigue severity (physical, mental) variables predicted HRQoL. In particular, it should be proved that fatigue is an important indicator of the HRQoL, so that the fatigue management should be useful in order to improve HRQoL. We decided to realize a comparative analysis between CFS and CHC patients because these two populations show similar pathomechanisms: HCV in CHC as well as unknown causal agents in CFS may playa crucial role in order to induce a cascade of events that finally lead to the production of oxidative damage, which in turn leads to the onset of fatigue and related symptoms (19) .
For this reason, the comparative analysis of "fatigue" in these two populations of patients should be useful to identify potential and still unclear pathomechanisms involved in the onset and/or perpetuation of CFS, having as model the HCV infection, a well recognized and defined chronic condition.
MATERIALS AND METHODS
We enrolIed 39 consecutive patients with a diagnosis ofCFS, as established by the second CDC case definition (6) , and 49 patients with chronic HCY virus infection. AlI participants had been diagnosed by a physician at the Clinic of Infectious Diseases of "G. d' Annunzio" University of Chieti (Italy) which is also a National Reference Center for the Study ofCFS. CFS patients were selected on the basis of a post-infectious onset for a better match with CHC patients: 9 patients developed CFS after a mononucleosis syndrome, 6 after an upper respiratory infection, 3 after a gastrointestinal infection, 2 after a varicelIa infection, 2 after Lyme disease and 17 after a flu-like syndrome. CHC patients showed the folIowing viral genotypes: genotype I in 23 cases, and genotype 2 or 3 in the remaining 26 cases. Furthermore, 30 on 49 of CHC patients (61.4%) showed normal liver function as expressed by the serum levels of transaminases. AlI patients gave their informed consent prior to their inclusion in the study. The exclusion criteria for this study were: the presence of any physical and/or psychiatric comorbidity that could justify the "fatigue", patients who had undergone medical treatment in the previous six months, and among CHC patients the presence of cirrhosis and/or hepatocarcinoma and/or a coinfection (e.g. HCY/HIY, HCY/HBY).
The patients' perception of "fatigue" was assessed using the "Fatigue Impact Scale" (FIS) (21) . The FIS examines patients' perceptions ofthe functional limitations that fatigue has caused over the previous month. FIS items reflect perceived impact on three domains: cognitive, physical and psychosocial. The independent scores can be analysed separately or as a combined score (ranging from oto 160) to give a general assessment of fatigue. Higher scores indicate that fatigue has a greater impact on the patient with more functional limitations.
The health-related quality of life (HRQoL) was assessed using the Health Status Questionnaire Short Form-36 (SF36) (22) . The SF36 is a widely used HRQoL measure that includes eight health status domains: physical functioning (limitations in physical functioning due to health problems), physical role (limitations in usual activities because of physical health problems), bodily pain, general health, vitality (energy and fatigue), social functioning (limitations in social functioning due to physical or emotional problems), emotional role (limitation in usual activities due to emotional problems) and mental health (psychological distress and welI-being). Each domain is scored 1-100, with higher scores indicating better health.
Data were analysed using the statistical software package SPSS version 14.0. Independent t-tests between the two subgroups of patients were performed for age, length of the illness, marital status, employment status, FIS and each subscale of the SF36. Multivariate linear regression analysis between partner status, employment status, length of the disease and all subscales of the FIS and SF36 was performed; furthermore, in Hey patients the multivariate linear regression analysis was carried out between fatigue and viral variables (genotype and viral load) and values of transaminases. Statistical significance was accepted at p:S 0.05.
RESULTS
The socio-demographic data of the two groups of patients are reported in Table I . No differences were found between the two groups regarding gender distribution and length of the disease. In particular, we found a higher prevalence in women of both chronic diseases than in men. In fact, of the CFS patients 15 were male and 24 female and of the CHC patients 22 were male and 27 female. The CHC population was older than the CFS population in a statistically significant way (p<O.OOO). In fact, the ages of the CFS patients ranged from 22 to 54 years with a mean age of39.8±7.73 years, while the ages of the CHC patients ranged from 41 to 65 years with a mean age of 50.2± 11.35 years. Furthermore, CFS and CHC patients showed a similar duration of the disease (86± 12.4 and 92± 11.2 months, respectively). There were statistically significant differences between the two groups in terms of employment and marital status: a consistent number of our CFS patients were unemployed or worked part-time (20/39; 51.3% of the sample), while CHC patients worked full-time in most of the cases, and 18% were retired. Regarding the partner status, CFS patients were mostly single (66.7% of the cases), and 32% were married. CHC patients were married in 76% of the cases and single in 24% of the cases. The prevalence of "fatigue" was 67.3% (33/49) in the CHC population and 100% (39/39) in the CFS population. The CFS patients reported significantly higher scores than the CHC patients at the FIS evaluation, both separately for each domain and as a global score (p<O.OOO) ( Fig. I a and b) . In particular, in both subgroups of patients the psychosocial domain was more compromised than the other FIS domains in a statistically significant way (p<O.OOO) (Fig. 2) . The scores of general health, physical and social ability (e.g.: physical functioning, physical role, social functioning, emotional role) subscales of SF-36 were significantly lower in CFS patients than in CHC subjects (p<O.OOO) ( Fig. 3) , while no differences were found between the two populations for the vitality subscale (p= 0.6) ( Fig. 4) . Meanwhile, the scores of the mental health domain and of bodily pain were found significantly higher in the CFS population than in the CHC population (p<O.O I) ( Fig. 5 ). Multivariate linear regression analysis did not reveal statistically significant positive variables in the CFS group for FIS and SF-36, while it revealed female gender as the most important positive variable in CHC patients for total score of FIS (p<O.O I) ( fig. 6 ).
DISCUSSION
At present, in developed countries the advances in medicine, as well as the improvement of the socio-economic status, lead the physician to meet an increasing number of chronic clinical conditions, where the disease chronically persists without necessarily resulting in death. For this reason, the doctor's attention is focused on ensuring a good and stable health status over time, as is well documented in the scientific literature (23) (24) (25) (26) . In this paper, we evaluated the HRQoL in patients living with chronic fatigue syndrome, a still poorly known disease in Italy, to establish the impact of the illness on all aspects of life of the individual patients, and to compare them with patients with chronic hepatitis C, a well-defined chronic disease where fatigue and HRQoL are known to induce a disabling condition. First of all, it is noteworthy that there is a forced "bias" represented by the lack of homogeneity of the two groups of patients regarding age. This is due to the epidemiology of these two chronic conditions, where CFS is more prevalent in younger patients (mean age: 20-35 years), while HCV infection is mostly identified in older patients. Despite being younger, CFS patients showed a major disabling condition in terms of inability to work compared to CHC patients (about half of the CFS patients vs 18% of the CHC patients) and higher prevalence of fatigue, even though this is obvious since "fatigue" represents the major criteria for CDC case definition for CFS (6) . Despite this, it is important to underline that a significant prevalence of fatigue (67.3%) was also found in CHC patients, and this agrees with the data in literature (27) (28) . In both conditions a causal role of oxidative stress in inducing fatigue is well documented (7, 19, 29) : fatigue represents the result of a cascade of immunological and endocrinological events caused by the oxidative damage (7) . Therefore, an infectious agent -not always identified ., IJ) "Percentage ofFlSalteration in CHC patients reg:miing gendRr Fig. 6 . Multivariate analvsis in CHC patients.
in CFS patients but well identified in CHC patientscould represent a triggering factor able to induce the oxidative damage and the related cascade of events.
As for the prevalence of fatigue, we observed a highly significant impairment of FIS domains and of almost all the aspects of daily life at SF-36 evaluation in CFS patients in comparison with CHC patients (Fig. I a, b, Fig. 2 ). In our opinion, this observation could be explained in the following way: in CFS patients the fatigue shows a severe impact on each domain, because there is a higher negative perception of the symptoms and disability than in other chronic well-defined conditions since they are unable to carry out any previously welltolerated daily activity in the total absence of an organic explanation for such disabling condition.
In addition, many CFS patients showing personality traits suggestive of perfectionism and narcissism are forced to leave their jobs, often resulting in a severe decline in the previous levels of self-esteem and mood. In spite of this, and according to the "fighting spirit" of CFS patients, they show a higher mental status score than CHC patients, while no differences between the two groups were found regarding the vitality subscale.
On the other hand, at FIS evaluation CHC patients showed a significant reduction of the psychosocial domain in comparison with the other domains (Fig.  2) . This is probably explained by two reasons: the "shame" of the illness due to the persisting belief that a person with hepatitis typically has a history characterised by drug abuse or promiscuous sexual activity, and the "fear" that CHC may evolve into a potentially lethal disease, such as cirrhosis and hepatocarcinoma (30) .
Finally, in CHC patients multivariate linear regression analysis revealed female gender as the most important positive variable for total score of FIS (Fig.  6) . In our opinion, in CHC patients muscle pain and fatigue can be explained by some typical endocrine and/or immune alterations: a reduction both of estrogen levels and estrogen receptors with an increase of oxidative damage; a decrease of the intrahepatic production of IGF-I which plays a crucial role in the homeostasis of skeletal muscle; a hyperstimulation of the immune system where the high circulating leptin levels in chronic hepatitis C seem to reflect the high levels of TNF-alpha, one of the most important inducers ofleptin secretion (31) (32) (33) .
In conclusion, our study suggests that in chronic infectious or post-infectious diseases it is typical to find a relevant "fatigue". Fatigue, in tum, could cause or contribute to causing both physical and pshychosocial discomfort that would lead to an impairment of HRQoL. Our study shows that CFS has a significant negative influence on almost all the domains of the daily life of patients in comparison with CHC. Probably, this is justified by the fact that in CFS the infection represents only one of several triggering factors that lead to the onset of the syndrome, whereas many other factors (psychological, neuroendocrine, immunological, toxic and environmental) may contribute to the onset and/or perpetuation of the syndrome.
In our opinion, it is important that further studies on fatigue and HRQoL in chronic fatigue syndrome should be carried out, not only to identify potential pathomechanisms able to satisfactorily explain this disorder, but also to improve the management and the well-being of both individual patients and their families and carers.
